Aeglea BioTherapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Aeglea BioTherapeutics Inc: Is Infosys Ltd. worth buying?
Item: Aeglea BioTherapeutics Inc
Rating: 1.80683325
Author: Trendlyne DVM scores

about

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient...

33.58 0.44 (1.33%)

Near 52W High of $35.31

570.9K

XNAS Volume

XNAS 29 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

5.8 / 100

Technically Moderately Bullish

66.4 / 100

No estimates available

Aeglea BioTherapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Aeglea BioTherapeutics Inc Live Stock Price Today, Share Analysis and Chart

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient...

Near 52W High of $35.31

SWOT Analysis

Aeglea BioTherapeutics Inc Live Price Chart